These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 31310686

  • 1. Blood eosinophil count correlates with severity of respiratory failure in life-threatening asthma and predicts risk of subsequent exacerbations.
    Yii ACA, Tay TR, Puah SH, Lim HF, Li A, Lau P, Tan R, Neo LP, Chung KF, Koh MS.
    Clin Exp Allergy; 2019 Dec; 49(12):1578-1586. PubMed ID: 31310686
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Blood eosinophil counts and arterial oxygen tension in acute asthma.
    Spallarossa D, Sacco O, Girosi D, Rossi GA.
    Arch Dis Child; 1995 Oct; 73(4):333-7. PubMed ID: 7492198
    [Abstract] [Full Text] [Related]

  • 4. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.
    Price DB, Rigazio A, Campbell JD, Bleecker ER, Corrigan CJ, Thomas M, Wenzel SE, Wilson AM, Small MB, Gopalan G, Ashton VL, Burden A, Hillyer EV, Kerkhof M, Pavord ID.
    Lancet Respir Med; 2015 Nov; 3(11):849-58. PubMed ID: 26493938
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study.
    Kerkhof M, Tran TN, van den Berge M, Brusselle GG, Gopalan G, Jones RCM, Kocks JWH, Menzies-Gow A, Nuevo J, Pavord ID, Rastogi S, Price DB.
    PLoS One; 2018 Nov; 13(7):e0201143. PubMed ID: 30044863
    [Abstract] [Full Text] [Related]

  • 7. Mild exacerbations and eosinophilic inflammation in patients with stable, well-controlled asthma after 1 year of follow-up.
    Belda J, Giner J, Casan P, Sanchis J.
    Chest; 2001 Apr; 119(4):1011-7. PubMed ID: 11296162
    [Abstract] [Full Text] [Related]

  • 8. Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
    Ortega HG, Yancey SW, Mayer B, Gunsoy NB, Keene ON, Bleecker ER, Brightling CE, Pavord ID.
    Lancet Respir Med; 2016 Jul; 4(7):549-556. PubMed ID: 27177493
    [Abstract] [Full Text] [Related]

  • 9. Association of Blood Eosinophil and Blood Neutrophil Counts with Asthma Exacerbations in the Copenhagen General Population Study.
    Vedel-Krogh S, Fallgaard Nielsen S, Lange P, Vestbo J, Nordestgaard BG.
    Clin Chem; 2017 Apr; 63(4):823-832. PubMed ID: 28209625
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma.
    Albers FC, Licskai C, Chanez P, Bratton DJ, Bradford ES, Yancey SW, Kwon N, Quirce S.
    Respir Med; 2019 Nov; 159():105806. PubMed ID: 31751853
    [Abstract] [Full Text] [Related]

  • 12. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
    Song JH, Lee CH, Kim JW, Lee WY, Jung JY, Park JH, Jung KS, Yoo KH, Park YB, Kim DK.
    Int J Chron Obstruct Pulmon Dis; 2017 Nov; 12():2455-2464. PubMed ID: 28860740
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adjusting prednisone using blood eosinophils reduces exacerbations and improves asthma control in difficult patients with asthma.
    Wark PA, McDonald VM, Gibson PG.
    Respirology; 2015 Nov; 20(8):1282-4. PubMed ID: 26268788
    [Abstract] [Full Text] [Related]

  • 17. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma.
    Katz LE, Gleich GJ, Hartley BF, Yancey SW, Ortega HG.
    Ann Am Thorac Soc; 2014 May; 11(4):531-6. PubMed ID: 24606022
    [Abstract] [Full Text] [Related]

  • 18. Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials.
    Bernstein JA, Virchow JC, Murphy K, Maspero JF, Jacobs J, Adir Y, Humbert M, Castro M, Marsteller DA, McElhattan J, Hickey L, Garin M, Vanlandingham R, Brusselle G.
    Lancet Respir Med; 2020 May; 8(5):461-474. PubMed ID: 32066536
    [Abstract] [Full Text] [Related]

  • 19. Blood Eosinophil Count and Outcomes in Severe Uncontrolled Asthma: A Prospective Study.
    Zeiger RS, Schatz M, Dalal AA, Chen W, Sadikova E, Suruki RY, Kawatkar AA, Qian L.
    J Allergy Clin Immunol Pract; 2017 May; 5(1):144-153.e8. PubMed ID: 27665383
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.